![Tamara McGrillen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Tamara McGrillen worked as the Head-Investor Relations at Galena Biopharma, Inc. from 2008 to 2012.
She also worked as an Investor Relations Contact at Phio Pharmaceuticals Corp.
Ms. McGrillen received her undergraduate degree from Curry College in 1993.
Precedenti posizioni note di Tamara McGrillen
Società | Posizione | Fine |
---|---|---|
Galena Biopharma, Inc.
![]() Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Contatto Relazioni con gli Investitori | 01/04/2012 |
PHIO PHARMACEUTICALS CORP. | Contatto Relazioni con gli Investitori | - |
Formazione di Tamara McGrillen
Curry College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PHIO PHARMACEUTICALS CORP. | Health Technology |
Aziende private | 1 |
---|---|
Galena Biopharma, Inc.
![]() Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Borsa valori
- Insiders
- Tamara McGrillen